Published in
Taylor and Francis Group, OncoImmunology, p. 1-14
DOI: 10.1080/2162402x.2018.1502904
Links
Tools
CD27 stimulation unveils the efficacy of linked class I/II peptide vaccines in poorly immunogenic tumors by orchestrating a coordinated CD4/CD8 T cell response
Journal article published in 2018 by
Katherine A. Riccione,
Li-Zhen He 
,
Peter E. Fecci ,
Pamela K. Norberg,
Carter M. Suryadevara,
Adam Swartz,
Patrick Healy,
Elizabeth Reap,
Tibor Keler,
Qi-Jing Li,
Kendra L. Congdon,
Luis Sanchez-Perez,
John H. Sampson
,
Peter E. Fecci ,
Pamela K. Norberg,
Carter M. Suryadevara,
Adam Swartz,
Patrick Healy,
Elizabeth Reap,
Tibor Keler,
Qi-Jing Li,
Kendra L. Congdon,
Luis Sanchez-Perez,
John H. Sampson
Distributing this paper is prohibited by the publisher
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 